Meeting of the Uniform Formulary Beneficiary Advisory Panel, 11423-11424 [2014-04405]

Download as PDF Federal Register / Vol. 79, No. 40 / Friday, February 28, 2014 / Notices W6QM MICC Ctr–Ft Dix (RC), Fort Dix, NJ. Barry S. Lineback, Director, Business Operations. Dated: February 25, 2014. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2014–04412 Filed 2–27–14; 8:45 am] [FR Doc. 2014–04416 Filed 2–27–14; 8:45 am] BILLING CODE 6353–01–P BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE DEPARTMENT OF DEFENSE Office of the Secretary Office of the Secretary Meeting of the Uniform Formulary Beneficiary Advisory Panel Request for Input for 2015 Department of Defense (DoD) Key State Issues Impacting Service Members and Their Families AGENCY: ACTION: Department of Defense. Assistant Secretary of Defense (Health Affairs), Department of Defense. ACTION: Notice of meeting. AGENCY: The Department of Defense is publishing this notice to announce the following meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel). This meeting is open to the public. DATES: March 20, 2014, from 9:00 a.m. to 1:00 p.m. ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Col J. Michael Spilker, DFO, Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Telephone: (703) 681–2890. Fax: (703) 681–1940. Email Address: Baprequests@dha.mil. SUMMARY: Notice. This notice provides an opportunity for the public to submit issues that have an impact on Service members and their families where state governments are the primary agents for making positive change. Each year, DoD selects issues for states to consider that represent barriers resulting from the transience and uncertainty of military life. For example, DoD has asked states to consider remedies to improve school transition for children in active duty military families to overcome problems with records transfer, class and course placement, qualifying for extracurricular activities, and fulfilling graduation requirements. SUMMARY: Marcus Beauregard, (571) 372–5357. This meeting is being held under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C. Appendix, as amended) and the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended). Purpose of Meeting: The Panel will review and comment on recommendations made to the Director of Defense Health Agency, by the Pharmacy and Therapeutics Committee, regarding the Uniform Formulary. Inputs should include the following information: A. Issue title. B. Description of the issue to include a description of the policy or practice, the impact and who is impacted by this issue. C. Description of the potential solution to this issue, to include whether the issue can be corrected through a change in state procedures, state regulations or state statute. D. Your contact information so that we can follow-up if we need any clarifications. Meeting Agenda 1. Sign-In. 2. Welcome and Opening Remarks. 3. Public Citizen Comments. 4. Scheduled Therapeutic Class Reviews (Comments will follow each agenda item). a. Pulmonary Agents-1. b. PEC Class: Gastrointestinal-1 Agents. c. PEC Class: Pancreatic Enzyme Agents. d. Designated Newly Approved Drugs in Already-Reviewed Classes. e. Pertinent Utilization Management Issues. 5. Panel Discussions and Vote. Inputs must be received by April 14, 2014. DATES: Electronic responses can be sent to: marcus.j.beauregard.civ@ mail.mil. Send correspondence to: Office of the Deputy Assistant Secretary of Defense, Military Community and Family Policy, 4000 Defense Pentagon, Washington, DC 20301–4000. ADDRESSES: FOR FURTHER INFORMATION CONTACT: tkelley on DSK3SPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Mar<15>2010 17:47 Feb 27, 2014 Jkt 232001 SUPPLEMENTARY INFORMATION: PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 11423 Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is limited and will be provided only to the first 220 people signing-in. All persons must sign-in legibly. Administrative Work Meeting: Prior to the public meeting, the Panel will conduct an Administrative Work Meeting from 8:00 a.m. to 9:00 a.m. to discuss administrative matters of the Panel. The Administrative Work Meeting will be held at the Naval Heritage Center, 701 Pennsylvania Avenue NW., Washington, DC 20004. Pursuant to 41 CFR 102–3.160, the Administrative Work Meeting will be closed to the public. Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140, the public or interested organizations may submit written statements to the membership of the Panel at any time or in response to the stated agenda of a planned meeting. Written statements should be submitted to the Panel’s Designated Federal Officer (DFO). The DFO’s contact information can be obtained from the General Services Administration’s Federal Advisory Committee Act Database at https:// facadatabase.gov/. Written statements that do not pertain to the scheduled meeting of the Panel may be submitted at any time. However, if individual comments pertain to a specific topic being discussed at a planned meeting, then these statements must be submitted no later than 5 business days prior to the meeting in question. The DFO will review all submitted written statements and provide copies to all the committee members. Public Comments: In addition to written statements, the Panel will set aside 1 hour for individuals or interested groups to address the Panel. To ensure consideration of their comments, individuals and interested groups should submit written statements as outlined in this notice; but if they still want to address the Panel, then they will be afforded the opportunity to register to address the Panel. The Panel’s DFO will have a ‘‘Sign-Up Roster’’ available at the Panel meeting for registration on a first-come, first-serve basis. Those wishing to address the Panel will be given no more than 5 minutes to present their comments, and at the end of the 1 hour time period, no further public comments will be accepted. Anyone who signs-up to address the Panel, but is unable to do so due to the time limitation, may submit their comments E:\FR\FM\28FEN1.SGM 28FEN1 11424 Federal Register / Vol. 79, No. 40 / Friday, February 28, 2014 / Notices in writing; however, they must understand that their written comments may not be reviewed prior to the Panel’s deliberation. To ensure timeliness of comments for the official record, the Panel encourages that individuals and interested groups consider submitting written statements instead of addressing the Panel. ADDRESSES: Dated: February 25, 2014. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. Notice of Availability of the Draft Environmental Impact Statement for the Installation of a Terminal Groin Structure at the Western End of South Beach, Bald Head Island, Adjacent to the Federal Wilmington Harbor Channel of the Cape Fear River (Brunswick County, NC), and ReScheduling of the Public Hearing Questions about the proposed action and DEIS can be directed to Mr. Ronnie Smith, Wilmington Regulatory Field Office, telephone: (910) 251–4829. Additional description of the VBHI proposal can be found at the following link, https://www.saw.usace.army.mil/ Missions/RegulatoryPermitProgram/ MajorProjects, under the VBHI Terminal Groin Project. SUPPLEMENTARY INFORMATION: Please reference the Notice of Availability that was filed in the Federal Register (79 FR 1843) on January 10, 2014 for project information, including alternatives. The DEIS has been published and circulated, and a public hearing will be held March 4, 2014 at the International Longshoreman’s Association Center, located at 211 West 10th Street in Southport, Brunswick County, North Carolina at 6 p.m. Department of the Army, U.S. Army Corps of Engineers, DoD. ACTION: Notice of availability. Dated: February 18, 2014. Scott McLendon, Chief, Regulatory Division. [FR Doc. 2014–04405 Filed 2–27–14; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Department of the Army; Corps of Engineers AGENCY: The U.S. Army Corps of Engineers (USACE), Wilmington District, Wilmington Regulatory Field Office has received a request for Department of the Army authorization, pursuant to Section 404 of the Clean Water Act and Section 10 of the Rivers and Harbor Act, from the Village of Bald Head Island (VBHI) to develop and implement a shoreline protection plan that includes the installation of a terminal groin structure on the east side of the Wilmington Harbor Baldhead Shoal Entrance Channel (a federallymaintained navigation channel of the Cape Fear River) at the ‘‘Point’’ of Bald Head Island. The structure will be designed to function in concert with Federal beach disposal operations associated with the Wilmington Harbor navigation project. This is a supplement to the notice published in the Federal Register (79 FR 1843) on January 10, 2014 and a revision to the date of the public hearing and an extension of the comment period. DATES: Due to inclement weather, the public hearing that was scheduled for February 12 was cancelled and rescheduled for March 4, 2014. Written comments on the DEIS will be received until March 17, 2014. tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:47 Feb 27, 2014 Jkt 232001 Copies of comments and questions regarding scoping of the DEIS may be submitted to: U.S. Army Corps of Engineers (Corps), Wilmington District, Regulatory Division. ATTN: File Number SAW–2012–00040, 69 Darlington Avenue, Wilmington, NC 28403. FOR FURTHER INFORMATION CONTACT: [FR Doc. 2014–04286 Filed 2–27–14; 8:45 am] BILLING CODE 3720–58–P DEPARTMENT OF DEFENSE Department of the Navy [Docket ID: USN–2013–0028] Submission for OMB Review; Comment Request ACTION: Notice. The Department of Defense has submitted to OMB for clearance, the following proposal for collection of information under the provisions of the Paperwork Reduction Act (44 U.S.C. Chapter 35). DATES: Consideration will be given to all comments received by March 31, 2014. FOR FURTHER INFORMATION CONTACT: Fred Licari, 571–372–0493. SUPPLEMENTARY INFORMATION: Title, Associated Form and OMB Number: U.S. Navy Chief of Information Sponsor Application; OMB Control Number 0703–0060. Type of Request: Extension. Number of Respondents: 3000. Responses per Respondent: 1. Annual Responses: 3000. SUMMARY: PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 Average Burden per Response: 15 minutes. Annual Burden Hours: 750. Needs and Uses: This collection of information is necessary to automate an antiquated process facilitating embarks on Navy surface ships and submarines. Affected Public: Members of the Public who accept invitations to embark Navy surface ships and submarines. Frequency: On occasion. Respondent’s Obligation: Required to Obtain or Retain Benefit. OMB Desk Officer: Ms. Jasmeet Seehra. Written comments and recommendations on the proposed information collection should be sent to Ms. Jasmeet Seehra at the Office of Management and Budget, Desk Officer for DoD, Room 10236, New Executive Office Building, Washington, DC 20503. You may also submit comments, identified by docket number and title, by the following method: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. Instructions: All submissions received must include the agency name, docket number and title for this Federal Register document. The general policy for comments and other submissions from members of the public is to make these submissions available for public viewing on the Internet at https:// www.regulations.gov as they are received without change, including any personal identifiers or contact information. DOD Clearance Officer: Ms. Patricia Toppings. Written requests for copies of the information collection proposal should be sent to Ms. Toppings at WHS/ESD Information Management Division, 4800 Mark Center Drive, East Tower, Suite 02G09, Alexandria, VA 22350–3100. Dated: February 25, 2014. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2014–04477 Filed 2–27–14; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Department of the Navy [Docket ID: USN–2013–0035] Submission for OMB Review; Comment Request ACTION: Notice. The Department of Defense has submitted to OMB for clearance, the following proposal for collection of SUMMARY: E:\FR\FM\28FEN1.SGM 28FEN1

Agencies

[Federal Register Volume 79, Number 40 (Friday, February 28, 2014)]
[Notices]
[Pages 11423-11424]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-04405]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Assistant Secretary of Defense (Health Affairs), Department of 
Defense.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing this notice to 
announce the following meeting of the Uniform Formulary Beneficiary 
Advisory Panel (hereafter referred to as the Panel). This meeting is 
open to the public.

DATES: March 20, 2014, from 9:00 a.m. to 1:00 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Col J. Michael Spilker, DFO, Uniform 
Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 
5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890. Fax: 
(703) 681-1940. Email Address: Baprequests@dha.mil.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C. 
Appendix, as amended) and the Government in the Sunshine Act of 1976 (5 
U.S.C. 552b, as amended).
    Purpose of Meeting: The Panel will review and comment on 
recommendations made to the Director of Defense Health Agency, by the 
Pharmacy and Therapeutics Committee, regarding the Uniform Formulary.

Meeting Agenda

1. Sign-In.
2. Welcome and Opening Remarks.
3. Public Citizen Comments.
4. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item).
    a. Pulmonary Agents-1.
    b. PEC Class: Gastrointestinal-1 Agents.
    c. PEC Class: Pancreatic Enzyme Agents.
    d. Designated Newly Approved Drugs in Already-Reviewed Classes.
    e. Pertinent Utilization Management Issues.
5. Panel Discussions and Vote.

    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 CFR 102-3.140 through 102-3.165, and the availability of space, this 
meeting is open to the public. Seating is limited and will be provided 
only to the first 220 people signing-in. All persons must sign-in 
legibly.
    Administrative Work Meeting: Prior to the public meeting, the Panel 
will conduct an Administrative Work Meeting from 8:00 a.m. to 9:00 a.m. 
to discuss administrative matters of the Panel. The Administrative Work 
Meeting will be held at the Naval Heritage Center, 701 Pennsylvania 
Avenue NW., Washington, DC 20004. Pursuant to 41 CFR 102-3.160, the 
Administrative Work Meeting will be closed to the public.
    Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-3.140, 
the public or interested organizations may submit written statements to 
the membership of the Panel at any time or in response to the stated 
agenda of a planned meeting. Written statements should be submitted to 
the Panel's Designated Federal Officer (DFO). The DFO's contact 
information can be obtained from the General Services Administration's 
Federal Advisory Committee Act Database at https://facadatabase.gov/.
    Written statements that do not pertain to the scheduled meeting of 
the Panel may be submitted at any time. However, if individual comments 
pertain to a specific topic being discussed at a planned meeting, then 
these statements must be submitted no later than 5 business days prior 
to the meeting in question. The DFO will review all submitted written 
statements and provide copies to all the committee members.
    Public Comments: In addition to written statements, the Panel will 
set aside 1 hour for individuals or interested groups to address the 
Panel. To ensure consideration of their comments, individuals and 
interested groups should submit written statements as outlined in this 
notice; but if they still want to address the Panel, then they will be 
afforded the opportunity to register to address the Panel. The Panel's 
DFO will have a ``Sign-Up Roster'' available at the Panel meeting for 
registration on a first-come, first-serve basis. Those wishing to 
address the Panel will be given no more than 5 minutes to present their 
comments, and at the end of the 1 hour time period, no further public 
comments will be accepted. Anyone who signs-up to address the Panel, 
but is unable to do so due to the time limitation, may submit their 
comments

[[Page 11424]]

in writing; however, they must understand that their written comments 
may not be reviewed prior to the Panel's deliberation.
    To ensure timeliness of comments for the official record, the Panel 
encourages that individuals and interested groups consider submitting 
written statements instead of addressing the Panel.

    Dated: February 25, 2014.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2014-04405 Filed 2-27-14; 8:45 am]
BILLING CODE 5001-06-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.